ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
Bests Market Segment Report: Record Catastrophe Bond Issuance Boosts ILS Capacity and Reshapes Pricing Landscape
OLDWICK, N.J.--(BUSINESS WIRE)--#insurance--Reinsurance pricing at the midyear 2025 renewals was the most…
